Substantial Reduction in Single Sympathetic Nerve Firing After Renal Denervation in Patients With Resistant Hypertension
Open accessAbstract
Renal denervation (RDN) has been shown to reduce blood pressure (BP) and muscle sympathetic nerve activity (MSNA) in patients with resistant hypertension. The mechanisms underlying sympathetic neural inhibition are unknown. We examined whether RDN differentially influences the sympathetic discharge pattern of vasoconstrictor neurons in patients with resistant hypertension. Standardized office BP, single-unit MSNA, and multi-unit MSNA were obtained at baseline and at 3-month follow-up in 35 patients with resistant hypertension. Twenty-five patients underwent RDN, and 10 patients underwent repeated measurements without RDN (non-RDN). Baseline BP averaged 164/93 mm Hg (RDN) and 164/87 mm Hg (non-RDN) despite use of an average of 4.8±0.4 and 4.4±0.5 antihypertensive drugs, respectively. Mean office BP decreased significantly by −13/−6 mm Hg for systolic BP ( P <0.001) and diastolic BP ( P <0.05) with RDN but not in non-RDN at 3-month follow-up. RDN moderately decreased multi-unit MSNA (79±3 versus 73±4 bursts/100 heartbeats; P <0.05), whereas all properties of single-unit MSNA including firing rates of individual vasoconstrictor fibers (43±5 versus 27±3 spikes/100 heartbeats; P <0.01), firing probability (30±2 versus 22±2% per heartbeat; P <0.02), and multiple firing incidence of single units within a cardiac cycle (8±1 versus 4±1% per heartbeat; P <0.05) were substantially reduced at follow-up. BP, single-unit MSNA, and multi-unit MSNA remained unaltered in the non-RDN cohort at follow-up. RDN results in the substantial and rapid reduction in firing properties of single sympathetic vasoconstrictor fibers, this being more pronounced than multi-unit MSNA inhibition. Whether the earlier changes in single-unit firing patterns may predict long-term BP response to RDN warrants further exploration.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Renal denervation slightly decreased muscle sympathetic nerve activity and blood pressure in patients with obesity and hypertension.
“Another study reported that RDN slightly decreased MSNA and BP in patients with obesity and hypertension171.”
From Obesity, kidney dysfunction and hypertension: mechanistic links (2019) · cites this paper as [171]
Ablation of the renal afferent nerves with endovascular delivery of radiofrequency energy in patients with drug-resistant hypertension causes inhibition of central sympathetic outflow.
“Ablation of the renal afferent nerves with endovascular delivery of radiofrequency energy in patients with drug-resistant hypertension causes inhibition of central sympathetic outflow21.”
From The Sympathetic Nervous System Alterations in Human Hypertension (2015) · cites this paper as [21]
Several open-label trials have documented the efficacy of renal denervation in subjects with resistant hypertension many of whom are obese.
“Several open-label trials have documented the efficacy of renal denervation in subjects with resistant hypertension many of whom are obese (24–28).”
From Obesity-Associated Hypertension: Recent Progress in Deciphering the Pathogenesis (2014) · cites this paper as [26]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 40 · Cited by 356
- Authors
- Hering, D., Lambert, E. A., Marusic, P., Walton, A. S., Krum, H., Lambert, G. W., Esler, M. D., & Schlaich, M. P.
- Affiliations
- Baker Heart and Diabetes Institute (AU)
- From the Neurovascular Hypertension and Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, Melbourne, Australia (D.H., E.A.L., P.M., G.W.L., M.D.E., M.P.S.); Department of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland (D.H.); Heart Centre Alfred Hospital, Melbourne, Australia (A.S.W., H.K., M.D.E., M.P.S.); Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia (H.K.); Faculty of Medicine, Nursing and Health Sciences...
- Venue
- Hypertension
- Published
- 2013-02
- Volume
- 61
- Issue
- 2
- Pages
- 457-464
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2114707939
- Cited by
- 356
- References
- 40
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 11 · 2023: 19 · 2022: 14 · 2021: 12 · 2020: 17 · 2019: 21 · 2018: 15 · 2017: 28 · 2016: 31 · 2015: 52 · 2014: 60 · 2013: 55 · 2012: 1
- FWCI
- 34.14
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Hypertension (publishedVersion)
- PubMed (publishedVersion)
- Swinburne figshare (Swinburne University of Technology) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Keywords
- renal denervation, resistant hypertension, muscle sympathetic nerve activity, blood pressure reduction
- MeSH terms
- Blood Pressure, Female, Heart Rate, Humans, Hypertension, Kidney, Male, Middle Aged, Neurons, Sympathectomy, Sympathetic Nervous System, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review